A global hunt for genes that influence heart disease risk has uncovered 157 changes in human DNA that alter the levels of cholesterol and other blood fats – a discovery that could lead to new medications.
Michigan’s top heart and heart surgery program has a new name – the University of Michigan Samuel and Jean Frankel Cardiovascular Center. The change recognizes $50 million in giving from the Samuel and Jean Frankel Foundation.
During Heart Disease Awareness Month, experts at the U-M Cardiovascular Center are available to discuss new strategies for improving patient care and the quality of patients' lives. While cutting-edge techniques are transforming treatment of heart disease, there are ways to prevent getting heart disease in the first place.
Want to know how well UMHS does at providing high-quality care and protecting patients' safety while they receive care? Check out the newly updated data on a website that provides these data, patient ratings of UMHS care, and much more, to the public.
The University of Michigan Cardiovascular Center, a leader in heart valve replacement, has performed its first minimally invasive aortic valve replacement. Designed to replace a diseased aortic heart valve percutaneously, the procedure potentially provides a safe and less invasive alternative to open heart surgery.
The University of Michigan Cardiovascular Center is part of the national Medtronic CoreValve trial to replace diseased valves with a minimally invasive procedure. It's a potentially transformative option for aortic stenosis patients who cannot tolerate open heart surgery.